Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome
NCT00394745
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Metabolic Syndrome
Interventions
DRUG:
Valsartan
Sponsor
Novartis